SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096411
Filing Date
2024-08-13
Accepted
2024-08-13 17:03:24
Documents
66
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rphm-20240630.htm   iXBRL 10-Q 1551292
2 EX-10.2 rphm-ex10_2.htm EX-10.2 48518
3 EX-10.3 rphm-ex10_3.htm EX-10.3 52952
4 EX-10.4 rphm-ex10_4.htm EX-10.4 50357
5 EX-10.5 rphm-ex10_5.htm EX-10.5 48126
6 EX-31.1 rphm-ex31_1.htm EX-31.1 16541
7 EX-31.2 rphm-ex31_2.htm EX-31.2 16328
8 EX-32.1 rphm-ex32_1.htm EX-32.1 14726
9 GRAPHIC img28451501_0.jpg GRAPHIC 11204
  Complete submission text file 0000950170-24-096411.txt   6493648

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rphm-20240630.xsd EX-101.SCH 1016809
68 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20240630_htm.xml XML 939041
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40315 | Film No.: 241202743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)